Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing.
Level 5 - mechanism / opinion, no new human data
Narrative review describing biological mechanisms without primary clinical trial data
PubMed 18627349 · doi:10.1089/ars.2008.2121
What was done
Narrative review synthesizing mechanistic pathways of endothelial progenitor cell (EPC) mobilization, homing, and neovascularization in diabetic wound healing, focusing on the effects of hyperbaric oxygen-induced hyperoxia and local stromal cell-derived factor-1 alpha (SDF-1alpha).
What was found
No quantitative data or effect sizes are reported in the abstract. The authors report that diabetes decreases circulating and wound EPC levels via bone marrow eNOS-NO pathway impairment; hyperoxia promotes EPC release from bone marrow into the peripheral circulation; mobilized EPCs fail to home to wounds due to downregulated local SDF-1alpha; and adding exogenous SDF-1alpha alongside hyperoxia synergistically enhances EPC homing, neovascularization, and diabetic wound healing.
Why it matters
It highlights that mobilizing progenitor cells with hyperoxia is insufficient on its own if local homing signals are deficient, providing a mechanistic rationale for combining systemic oxygen therapy with targeted chemokine delivery.
Limits
This is a narrative review with no primary clinical trial data, sample size, or quantitative metrics reported in the abstract. Findings are mechanism-based and largely derived from preclinical models, precluding direct conclusions about human clinical efficacy.
Cited by
- supports Hyperbaric oxygen therapy increases oxygen delivery, nerve growth factors, stem cell mobilization, and capillary perfusion.